| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fusobacterium Infections | 6 | 2023 | 7 | 2.750 |
Why?
|
| Sequence Analysis, DNA | 28 | 2023 | 508 | 2.330 |
Why?
|
| Receptors, Antigen, T-Cell | 10 | 2024 | 66 | 2.270 |
Why?
|
| Fusobacterium nucleatum | 6 | 2023 | 9 | 2.150 |
Why?
|
| T-Lymphocytes | 9 | 2024 | 378 | 1.370 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2019 | 59 | 1.350 |
Why?
|
| Genome, Human | 17 | 2014 | 143 | 1.310 |
Why?
|
| Mutation | 21 | 2020 | 1169 | 1.130 |
Why?
|
| Antigens, Neoplasm | 8 | 2020 | 77 | 1.110 |
Why?
|
| Genome | 13 | 2017 | 149 | 1.070 |
Why?
|
| Streptococcus mutans | 7 | 2008 | 14 | 1.050 |
Why?
|
| Hematologic Neoplasms | 3 | 2022 | 18 | 0.960 |
Why?
|
| CD8-Positive T-Lymphocytes | 5 | 2024 | 181 | 0.960 |
Why?
|
| Neoplasms | 11 | 2024 | 1341 | 0.940 |
Why?
|
| Gene Library | 18 | 2019 | 60 | 0.900 |
Why?
|
| Colorectal Neoplasms | 3 | 2023 | 502 | 0.880 |
Why?
|
| Base Sequence | 21 | 2017 | 997 | 0.860 |
Why?
|
| Gene Expression Profiling | 18 | 2013 | 683 | 0.790 |
Why?
|
| Bacterial Proteins | 11 | 2019 | 580 | 0.790 |
Why?
|
| Humans | 84 | 2024 | 42163 | 0.780 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2024 | 26 | 0.770 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2022 | 40 | 0.770 |
Why?
|
| Genome, Bacterial | 5 | 2011 | 132 | 0.730 |
Why?
|
| Vaccines | 1 | 2023 | 64 | 0.730 |
Why?
|
| Immunotherapy, Adoptive | 4 | 2024 | 16 | 0.730 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2020 | 29 | 0.670 |
Why?
|
| Sequence Analysis, RNA | 4 | 2017 | 114 | 0.660 |
Why?
|
| Peptide Library | 1 | 2019 | 27 | 0.630 |
Why?
|
| DNA | 6 | 2023 | 594 | 0.620 |
Why?
|
| Cancer Vaccines | 4 | 2016 | 26 | 0.600 |
Why?
|
| Bacterial Adhesion | 3 | 2008 | 40 | 0.600 |
Why?
|
| Major Histocompatibility Complex | 3 | 2016 | 27 | 0.570 |
Why?
|
| Molecular Sequence Data | 21 | 2014 | 1559 | 0.550 |
Why?
|
| Membrane Glycoproteins | 5 | 2003 | 221 | 0.540 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2017 | 4 | 0.540 |
Why?
|
| Gene Dosage | 5 | 2010 | 75 | 0.530 |
Why?
|
| Computational Biology | 12 | 2019 | 324 | 0.520 |
Why?
|
| Evolution, Molecular | 10 | 2010 | 299 | 0.510 |
Why?
|
| Plasminogen | 2 | 2007 | 10 | 0.500 |
Why?
|
| Immune System | 2 | 2015 | 40 | 0.500 |
Why?
|
| Genomics | 11 | 2018 | 289 | 0.500 |
Why?
|
| Religious Philosophies | 1 | 2015 | 1 | 0.490 |
Why?
|
| Ovarian Neoplasms | 3 | 2018 | 406 | 0.480 |
Why?
|
| Animals | 50 | 2024 | 16695 | 0.460 |
Why?
|
| Expressed Sequence Tags | 10 | 2010 | 27 | 0.460 |
Why?
|
| Plasmids | 6 | 2023 | 247 | 0.460 |
Why?
|
| DNA, Complementary | 9 | 2010 | 195 | 0.440 |
Why?
|
| Gene Duplication | 6 | 2012 | 24 | 0.440 |
Why?
|
| Escherichia coli | 4 | 2007 | 461 | 0.440 |
Why?
|
| Antigen-Presenting Cells | 1 | 2014 | 31 | 0.430 |
Why?
|
| Peptides | 3 | 2016 | 357 | 0.420 |
Why?
|
| Genetic Engineering | 2 | 2017 | 36 | 0.410 |
Why?
|
| Brain | 7 | 2019 | 1452 | 0.400 |
Why?
|
| Immunotherapy | 7 | 2020 | 137 | 0.400 |
Why?
|
| Sequence Analysis | 2 | 2020 | 26 | 0.400 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2012 | 44 | 0.380 |
Why?
|
| Chromosomes, Artificial, Bacterial | 9 | 2014 | 15 | 0.380 |
Why?
|
| Antigens | 2 | 2016 | 58 | 0.380 |
Why?
|
| Software | 5 | 2009 | 234 | 0.370 |
Why?
|
| Cloning, Molecular | 9 | 2010 | 318 | 0.370 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 150 | 0.360 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2024 | 25 | 0.360 |
Why?
|
| Promoter Regions, Genetic | 7 | 2019 | 534 | 0.360 |
Why?
|
| RNA, Viral | 2 | 2011 | 317 | 0.360 |
Why?
|
| Algorithms | 4 | 2010 | 508 | 0.350 |
Why?
|
| Caenorhabditis elegans | 6 | 2009 | 78 | 0.340 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 91 | 0.340 |
Why?
|
| Polyploidy | 2 | 2010 | 8 | 0.330 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 233 | 0.330 |
Why?
|
| Fibronectins | 2 | 2008 | 69 | 0.320 |
Why?
|
| Cell Line, Tumor | 8 | 2020 | 2598 | 0.320 |
Why?
|
| Contig Mapping | 4 | 2010 | 8 | 0.320 |
Why?
|
| Integrases | 3 | 2019 | 29 | 0.310 |
Why?
|
| ras Proteins | 1 | 2010 | 54 | 0.310 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2009 | 1 | 0.310 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2011 | 246 | 0.310 |
Why?
|
| Mice, Transgenic | 4 | 2019 | 658 | 0.310 |
Why?
|
| Databases, Genetic | 9 | 2010 | 103 | 0.310 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2009 | 2 | 0.300 |
Why?
|
| Schizophrenia | 3 | 2010 | 91 | 0.300 |
Why?
|
| Genome, Plant | 5 | 2016 | 29 | 0.300 |
Why?
|
| Oxidoreductases | 3 | 2004 | 79 | 0.300 |
Why?
|
| Chromosome Aberrations | 2 | 2006 | 61 | 0.300 |
Why?
|
| Anopheles | 3 | 2004 | 20 | 0.300 |
Why?
|
| Chromosome Mapping | 4 | 2007 | 198 | 0.290 |
Why?
|
| DNA Copy Number Variations | 5 | 2018 | 37 | 0.290 |
Why?
|
| Citrobacter | 3 | 2004 | 3 | 0.290 |
Why?
|
| Lung Neoplasms | 4 | 2018 | 479 | 0.290 |
Why?
|
| Endocarditis, Bacterial | 1 | 2008 | 6 | 0.290 |
Why?
|
| Mycoplasma genitalium | 1 | 2008 | 3 | 0.290 |
Why?
|
| Genes, Synthetic | 1 | 2008 | 5 | 0.290 |
Why?
|
| Phylogeny | 10 | 2017 | 740 | 0.280 |
Why?
|
| Streptococcus sobrinus | 3 | 2000 | 3 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2010 | 255 | 0.280 |
Why?
|
| Peptide Fragments | 1 | 2010 | 301 | 0.280 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 36 | 0.280 |
Why?
|
| Viral Proteins | 3 | 2006 | 196 | 0.280 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2007 | 33 | 0.280 |
Why?
|
| Recombination, Genetic | 2 | 2016 | 96 | 0.270 |
Why?
|
| Haemophilus influenzae | 1 | 2007 | 6 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 1804 | 0.270 |
Why?
|
| Genetic Variation | 7 | 2011 | 429 | 0.270 |
Why?
|
| Gene Silencing | 1 | 2008 | 154 | 0.270 |
Why?
|
| Picea | 3 | 2016 | 4 | 0.260 |
Why?
|
| Signal Transduction | 7 | 2017 | 2111 | 0.260 |
Why?
|
| Eye | 2 | 2019 | 80 | 0.260 |
Why?
|
| Xenopus laevis | 2 | 2006 | 72 | 0.260 |
Why?
|
| Sulfoxides | 2 | 2004 | 17 | 0.260 |
Why?
|
| Iron-Sulfur Proteins | 2 | 2004 | 15 | 0.260 |
Why?
|
| Male | 23 | 2022 | 22779 | 0.260 |
Why?
|
| Multigene Family | 5 | 2019 | 105 | 0.260 |
Why?
|
| Immunologic Memory | 2 | 2020 | 41 | 0.250 |
Why?
|
| Open Reading Frames | 8 | 2009 | 81 | 0.250 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2007 | 12 | 0.250 |
Why?
|
| Xenopus | 1 | 2006 | 47 | 0.250 |
Why?
|
| High-Throughput Screening Assays | 2 | 2019 | 72 | 0.250 |
Why?
|
| Gorilla gorilla | 1 | 2005 | 4 | 0.250 |
Why?
|
| Cluster Analysis | 7 | 2018 | 206 | 0.250 |
Why?
|
| Pan troglodytes | 1 | 2005 | 21 | 0.240 |
Why?
|
| Gene Expression | 5 | 2016 | 692 | 0.240 |
Why?
|
| Mesothelioma | 2 | 2018 | 148 | 0.240 |
Why?
|
| Models, Genetic | 5 | 2019 | 181 | 0.240 |
Why?
|
| Female | 25 | 2024 | 24018 | 0.240 |
Why?
|
| Antigens, CD19 | 2 | 2022 | 15 | 0.240 |
Why?
|
| Microsatellite Repeats | 1 | 2005 | 60 | 0.230 |
Why?
|
| Mice | 18 | 2024 | 6490 | 0.230 |
Why?
|
| Streptococcus | 3 | 2008 | 18 | 0.230 |
Why?
|
| Alleles | 4 | 2014 | 352 | 0.230 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2013 | 50 | 0.230 |
Why?
|
| Bipolar Disorder | 1 | 2006 | 83 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2018 | 860 | 0.230 |
Why?
|
| Aged | 12 | 2022 | 7982 | 0.230 |
Why?
|
| Glutamic Acid | 1 | 2006 | 131 | 0.230 |
Why?
|
| Plasminogen Activators | 1 | 2004 | 4 | 0.230 |
Why?
|
| Neoplasm Proteins | 3 | 2017 | 228 | 0.220 |
Why?
|
| Fibrinolysin | 1 | 2004 | 9 | 0.220 |
Why?
|
| Serratia | 1 | 2004 | 1 | 0.220 |
Why?
|
| Klebsiella | 1 | 2004 | 3 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 290 | 0.220 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 3 | 2019 | 21 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 727 | 0.220 |
Why?
|
| Hydatidiform Mole | 2 | 2014 | 2 | 0.220 |
Why?
|
| Gene Expression Regulation | 6 | 2013 | 1066 | 0.210 |
Why?
|
| DNA, Neoplasm | 2 | 2015 | 92 | 0.210 |
Why?
|
| Genes, Insect | 2 | 2002 | 27 | 0.210 |
Why?
|
| Hunger | 1 | 2023 | 12 | 0.210 |
Why?
|
| Nucleotides | 2 | 2016 | 37 | 0.200 |
Why?
|
| Populus | 3 | 2008 | 3 | 0.200 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2020 | 40 | 0.200 |
Why?
|
| Gene Knock-In Techniques | 3 | 2019 | 15 | 0.200 |
Why?
|
| Protein Binding | 5 | 2010 | 1076 | 0.200 |
Why?
|
| Databases, Nucleic Acid | 5 | 2019 | 30 | 0.200 |
Why?
|
| Genes, Plant | 3 | 2008 | 22 | 0.200 |
Why?
|
| Fibrinogen | 1 | 2002 | 24 | 0.200 |
Why?
|
| Host-Pathogen Interactions | 2 | 2021 | 203 | 0.190 |
Why?
|
| Cyclophosphamide | 1 | 2022 | 58 | 0.190 |
Why?
|
| Recurrence | 1 | 2022 | 149 | 0.190 |
Why?
|
| Antigens, Surface | 2 | 1994 | 50 | 0.190 |
Why?
|
| Drosophila | 1 | 2023 | 150 | 0.190 |
Why?
|
| Genes, Bacterial | 3 | 1996 | 92 | 0.190 |
Why?
|
| Bacteroides Infections | 1 | 2022 | 1 | 0.190 |
Why?
|
| Bacteroides fragilis | 1 | 2022 | 2 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 78 | 0.190 |
Why?
|
| Antigen Presentation | 2 | 2014 | 59 | 0.190 |
Why?
|
| Metagenome | 2 | 2012 | 31 | 0.190 |
Why?
|
| Chemokine CCL20 | 1 | 2021 | 9 | 0.180 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2013 | 22 | 0.180 |
Why?
|
| Cell Line | 4 | 2021 | 1416 | 0.180 |
Why?
|
| Antigens, Bacterial | 2 | 1994 | 144 | 0.180 |
Why?
|
| Biomedical Research | 2 | 2022 | 467 | 0.180 |
Why?
|
| Pinus | 3 | 2011 | 5 | 0.170 |
Why?
|
| Ophiostomatales | 2 | 2011 | 2 | 0.170 |
Why?
|
| DNA, Bacterial | 3 | 2008 | 207 | 0.170 |
Why?
|
| Canada | 4 | 2021 | 157 | 0.170 |
Why?
|
| Genome, Fungal | 2 | 2011 | 28 | 0.160 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2020 | 68 | 0.160 |
Why?
|
| Periplasm | 1 | 2000 | 3 | 0.160 |
Why?
|
| Epitopes | 3 | 2016 | 155 | 0.160 |
Why?
|
| Asbestos | 2 | 2018 | 57 | 0.160 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 53 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 557 | 0.160 |
Why?
|
| Transcription, Genetic | 5 | 2011 | 599 | 0.160 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 2803 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 2 | 1998 | 176 | 0.160 |
Why?
|
| Haplotypes | 3 | 2013 | 197 | 0.160 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2019 | 31 | 0.160 |
Why?
|
| Coculture Techniques | 1 | 2019 | 105 | 0.150 |
Why?
|
| Caenorhabditis elegans Proteins | 4 | 2009 | 41 | 0.150 |
Why?
|
| Models, Biological | 4 | 2011 | 711 | 0.150 |
Why?
|
| DNA Glycosylases | 1 | 2019 | 17 | 0.150 |
Why?
|
| RNA, Messenger | 7 | 2015 | 1265 | 0.150 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 2006 | 90 | 0.150 |
Why?
|
| Rheumatology | 1 | 2019 | 17 | 0.150 |
Why?
|
| Leukemia | 1 | 2019 | 54 | 0.150 |
Why?
|
| Physicians | 1 | 2021 | 180 | 0.150 |
Why?
|
| Sequence Alignment | 7 | 2010 | 273 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2019 | 53 | 0.150 |
Why?
|
| Tamoxifen | 1 | 2019 | 67 | 0.150 |
Why?
|
| Middle Aged | 13 | 2022 | 11819 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2021 | 324 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 301 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2013 | 310 | 0.140 |
Why?
|
| Amino Acid Sequence | 6 | 2010 | 1188 | 0.140 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2018 | 7 | 0.140 |
Why?
|
| Adult | 12 | 2022 | 13458 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 144 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2019 | 60 | 0.140 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 173 | 0.140 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 1679 | 0.140 |
Why?
|
| Epithelial Cells | 1 | 2021 | 426 | 0.140 |
Why?
|
| Ascomycota | 2 | 2009 | 21 | 0.140 |
Why?
|
| Neurofibromin 2 | 1 | 2018 | 5 | 0.140 |
Why?
|
| Physical Chromosome Mapping | 4 | 2007 | 12 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 32 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 230 | 0.140 |
Why?
|
| Rana catesbeiana | 1 | 2017 | 29 | 0.140 |
Why?
|
| Treatment Outcome | 3 | 2020 | 1586 | 0.140 |
Why?
|
| Flow Cytometry | 2 | 2017 | 411 | 0.130 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 55 | 0.130 |
Why?
|
| Insect Vectors | 2 | 2010 | 26 | 0.130 |
Why?
|
| Clone Cells | 1 | 2017 | 50 | 0.130 |
Why?
|
| Immunophenotyping | 1 | 2017 | 57 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2010 | 933 | 0.130 |
Why?
|
| Diphtheria Toxin | 1 | 2016 | 3 | 0.130 |
Why?
|
| Lymphocyte Depletion | 1 | 2016 | 13 | 0.130 |
Why?
|
| Drosophila melanogaster | 3 | 2023 | 189 | 0.130 |
Why?
|
| Disease Outbreaks | 2 | 2011 | 169 | 0.130 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 2 | 2014 | 6 | 0.130 |
Why?
|
| Chloroplasts | 1 | 2016 | 7 | 0.130 |
Why?
|
| Trinucleotide Repeats | 2 | 2007 | 5 | 0.130 |
Why?
|
| Gene Fusion | 2 | 2013 | 7 | 0.130 |
Why?
|
| Dependovirus | 1 | 2016 | 16 | 0.130 |
Why?
|
| DNA Repair Enzymes | 1 | 2016 | 22 | 0.130 |
Why?
|
| Embryonic Stem Cells | 4 | 2013 | 55 | 0.120 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1996 | 58 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2019 | 206 | 0.120 |
Why?
|
| Immunogenetics | 1 | 2015 | 2 | 0.120 |
Why?
|
| Rhodococcus | 2 | 2006 | 6 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 222 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 9 | 0.120 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 15 | 0.120 |
Why?
|
| Genes, Neoplasm | 3 | 2010 | 14 | 0.120 |
Why?
|
| Species Specificity | 6 | 2009 | 279 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2019 | 1617 | 0.120 |
Why?
|
| Genes, p53 | 1 | 2015 | 28 | 0.120 |
Why?
|
| HLA Antigens | 2 | 2018 | 27 | 0.120 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 55 | 0.110 |
Why?
|
| Genes, Immunoglobulin Light Chain | 1 | 2014 | 2 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 77 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 649 | 0.110 |
Why?
|
| Enzymes | 3 | 2006 | 34 | 0.110 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2015 | 89 | 0.110 |
Why?
|
| Glioma | 1 | 2015 | 92 | 0.110 |
Why?
|
| Genes | 3 | 2009 | 56 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 602 | 0.110 |
Why?
|
| Microarray Analysis | 1 | 2014 | 64 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 116 | 0.110 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2013 | 14 | 0.110 |
Why?
|
| Gene Regulatory Networks | 2 | 2012 | 143 | 0.110 |
Why?
|
| Chromosomes, Human, X | 1 | 2013 | 23 | 0.100 |
Why?
|
| Homozygote | 1 | 2013 | 77 | 0.100 |
Why?
|
| Genetic Vectors | 2 | 2016 | 165 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2014 | 88 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2008 | 293 | 0.100 |
Why?
|
| Transcription Factors | 3 | 2010 | 722 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2011 | 303 | 0.100 |
Why?
|
| Caspases | 1 | 2013 | 148 | 0.100 |
Why?
|
| DNA Transposable Elements | 3 | 2004 | 50 | 0.100 |
Why?
|
| Genes, Fungal | 2 | 2010 | 34 | 0.100 |
Why?
|
| Central Nervous System Bacterial Infections | 1 | 2013 | 1 | 0.100 |
Why?
|
| Cerebrum | 1 | 2013 | 2 | 0.100 |
Why?
|
| Fungal Proteins | 2 | 2011 | 143 | 0.100 |
Why?
|
| Alphaproteobacteria | 1 | 2013 | 7 | 0.100 |
Why?
|
| RNA, Ribosomal | 1 | 2013 | 30 | 0.100 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2013 | 57 | 0.100 |
Why?
|
| Golgi Apparatus | 1 | 2012 | 28 | 0.100 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2013 | 36 | 0.100 |
Why?
|
| RNA, Bacterial | 1 | 2013 | 38 | 0.100 |
Why?
|
| Encephalitis, Viral | 1 | 2012 | 6 | 0.100 |
Why?
|
| Genomic Structural Variation | 1 | 2012 | 1 | 0.100 |
Why?
|
| Rabies virus | 1 | 2012 | 3 | 0.100 |
Why?
|
| Rabies | 1 | 2012 | 4 | 0.100 |
Why?
|
| Medulloblastoma | 1 | 2012 | 3 | 0.100 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2011 | 99 | 0.100 |
Why?
|
| Cerebellar Neoplasms | 1 | 2012 | 4 | 0.100 |
Why?
|
| Metabolome | 1 | 2012 | 50 | 0.090 |
Why?
|
| Intestine, Large | 1 | 2011 | 5 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2006 | 71 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 129 | 0.090 |
Why?
|
| Mutagenesis | 2 | 2009 | 92 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 2012 | 318 | 0.090 |
Why?
|
| Binding Sites | 3 | 2008 | 670 | 0.090 |
Why?
|
| Genes, env | 1 | 2011 | 13 | 0.090 |
Why?
|
| Bacillus megaterium | 1 | 2011 | 3 | 0.090 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2011 | 10 | 0.090 |
Why?
|
| RNA Viruses | 1 | 2011 | 22 | 0.090 |
Why?
|
| Endogenous Retroviruses | 1 | 2011 | 17 | 0.090 |
Why?
|
| Proteome | 2 | 2002 | 150 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 382 | 0.090 |
Why?
|
| Stereoisomerism | 4 | 2004 | 166 | 0.090 |
Why?
|
| Alkynes | 1 | 2011 | 50 | 0.090 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2011 | 32 | 0.090 |
Why?
|
| Limit of Detection | 1 | 2011 | 82 | 0.090 |
Why?
|
| Plant Bark | 1 | 2010 | 8 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2010 | 2 | 0.080 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2013 | 225 | 0.080 |
Why?
|
| Trees | 1 | 2010 | 21 | 0.080 |
Why?
|
| Salmo salar | 1 | 2010 | 1 | 0.080 |
Why?
|
| Esocidae | 1 | 2010 | 3 | 0.080 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2010 | 19 | 0.080 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2010 | 35 | 0.080 |
Why?
|
| Lymphoma, Follicular | 1 | 2010 | 3 | 0.080 |
Why?
|
| Germinal Center | 1 | 2010 | 11 | 0.080 |
Why?
|
| Hela Cells | 1 | 2011 | 370 | 0.080 |
Why?
|
| Tuberculosis | 1 | 2011 | 76 | 0.080 |
Why?
|
| Synaptic Vesicles | 1 | 2010 | 31 | 0.080 |
Why?
|
| Epitope Mapping | 1 | 2010 | 31 | 0.080 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2022 | 106 | 0.080 |
Why?
|
| Lepidoptera | 2 | 2008 | 10 | 0.080 |
Why?
|
| Adaptive Immunity | 1 | 2010 | 32 | 0.080 |
Why?
|
| Synteny | 3 | 2009 | 18 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 2 | 2007 | 18 | 0.080 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2011 | 106 | 0.080 |
Why?
|
| Electrophoresis | 1 | 2009 | 24 | 0.080 |
Why?
|
| VDJ Recombinases | 1 | 2009 | 2 | 0.080 |
Why?
|
| Gene Order | 2 | 2007 | 17 | 0.080 |
Why?
|
| Antibody Diversity | 1 | 2009 | 11 | 0.080 |
Why?
|
| Genes, Helminth | 1 | 2009 | 7 | 0.080 |
Why?
|
| Eating | 2 | 2008 | 164 | 0.080 |
Why?
|
| Untranslated Regions | 2 | 2008 | 6 | 0.080 |
Why?
|
| Feeding Behavior | 2 | 2023 | 461 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 159 | 0.080 |
Why?
|
| Muscle Development | 1 | 2009 | 51 | 0.080 |
Why?
|
| Salmonidae | 1 | 2008 | 4 | 0.080 |
Why?
|
| Androgens | 1 | 2009 | 107 | 0.070 |
Why?
|
| DNA, Plant | 1 | 2008 | 10 | 0.070 |
Why?
|
| Mammals | 1 | 2009 | 109 | 0.070 |
Why?
|
| Loss of Heterozygosity | 2 | 2019 | 19 | 0.070 |
Why?
|
| Gene Expression Regulation, Plant | 2 | 2007 | 65 | 0.070 |
Why?
|
| Insect Proteins | 3 | 2006 | 51 | 0.070 |
Why?
|
| Databases as Topic | 2 | 2005 | 24 | 0.070 |
Why?
|
| Germ Cells | 1 | 2009 | 74 | 0.070 |
Why?
|
| Templates, Genetic | 1 | 2008 | 24 | 0.070 |
Why?
|
| DNA Primers | 2 | 2006 | 295 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 1058 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2019 | 1729 | 0.070 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2008 | 8 | 0.070 |
Why?
|
| Adolescent | 5 | 2020 | 5950 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 287 | 0.070 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 200 | 0.070 |
Why?
|
| 3' Untranslated Regions | 2 | 2005 | 81 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 49 | 0.070 |
Why?
|
| Embryonic Induction | 1 | 2007 | 3 | 0.070 |
Why?
|
| Taste Buds | 1 | 2007 | 3 | 0.070 |
Why?
|
| Social Support | 1 | 2011 | 438 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 271 | 0.070 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2007 | 11 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2007 | 29 | 0.070 |
Why?
|
| CpG Islands | 3 | 2015 | 107 | 0.070 |
Why?
|
| Mouth | 1 | 2007 | 49 | 0.070 |
Why?
|
| Neurons, Afferent | 1 | 2007 | 44 | 0.070 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2007 | 1 | 0.070 |
Why?
|
| Substrate Specificity | 2 | 2004 | 217 | 0.070 |
Why?
|
| Pseudomonas putida | 2 | 2004 | 10 | 0.070 |
Why?
|
| Vitis | 1 | 2007 | 37 | 0.070 |
Why?
|
| GATA Transcription Factors | 1 | 2006 | 3 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2007 | 30 | 0.060 |
Why?
|
| Metabolism | 1 | 2006 | 9 | 0.060 |
Why?
|
| Genotype | 4 | 2013 | 796 | 0.060 |
Why?
|
| Fluorescent Dyes | 2 | 1998 | 182 | 0.060 |
Why?
|
| Colobinae | 1 | 2006 | 1 | 0.060 |
Why?
|
| Genes, Duplicate | 1 | 2006 | 4 | 0.060 |
Why?
|
| Bacteriophage P1 | 1 | 2006 | 1 | 0.060 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2006 | 30 | 0.060 |
Why?
|
| Receptors, Kainic Acid | 1 | 2006 | 11 | 0.060 |
Why?
|
| Chromosome Inversion | 2 | 2002 | 9 | 0.060 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2006 | 11 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2006 | 54 | 0.060 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2007 | 168 | 0.060 |
Why?
|
| Frontal Lobe | 1 | 2006 | 58 | 0.060 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2005 | 3 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2006 | 74 | 0.060 |
Why?
|
| Chromosomes | 2 | 2002 | 44 | 0.060 |
Why?
|
| Huntington Disease | 1 | 2005 | 31 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2005 | 35 | 0.060 |
Why?
|
| Receptor, Insulin | 1 | 2005 | 26 | 0.060 |
Why?
|
| Influenza in Birds | 1 | 2004 | 11 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 506 | 0.060 |
Why?
|
| Influenza A virus | 1 | 2004 | 31 | 0.060 |
Why?
|
| Germ-Line Mutation | 2 | 2019 | 74 | 0.060 |
Why?
|
| Environmental Microbiology | 1 | 2004 | 27 | 0.050 |
Why?
|
| Kinetics | 1 | 2006 | 698 | 0.050 |
Why?
|
| Histones | 1 | 2005 | 194 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 686 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2004 | 168 | 0.050 |
Why?
|
| Rats, Inbred BN | 1 | 2004 | 21 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 206 | 0.050 |
Why?
|
| Safrole | 1 | 2004 | 2 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2004 | 93 | 0.050 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2004 | 46 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 2 | 2017 | 34 | 0.050 |
Why?
|
| Biocatalysis | 1 | 2004 | 30 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2018 | 214 | 0.050 |
Why?
|
| Nanotechnology | 1 | 2005 | 176 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2004 | 462 | 0.050 |
Why?
|
| Oxidation-Reduction | 4 | 2011 | 448 | 0.050 |
Why?
|
| RNA, Neoplasm | 2 | 2015 | 25 | 0.050 |
Why?
|
| Longevity | 1 | 2005 | 171 | 0.050 |
Why?
|
| Digestion | 1 | 2002 | 14 | 0.050 |
Why?
|
| MicroRNAs | 3 | 2015 | 501 | 0.050 |
Why?
|
| Collagen Type I | 1 | 2002 | 35 | 0.050 |
Why?
|
| Thiosulfonic Acids | 1 | 2002 | 1 | 0.050 |
Why?
|
| Adhesins, Bacterial | 1 | 2002 | 20 | 0.050 |
Why?
|
| Blood | 1 | 2002 | 37 | 0.050 |
Why?
|
| Mosquito Control | 1 | 2002 | 15 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2003 | 118 | 0.050 |
Why?
|
| Laminin | 1 | 2002 | 58 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2010 | 972 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 457 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2002 | 116 | 0.050 |
Why?
|
| Minority Health | 1 | 2022 | 96 | 0.050 |
Why?
|
| Malaria, Falciparum | 1 | 2002 | 91 | 0.040 |
Why?
|
| Proteins | 3 | 2012 | 383 | 0.040 |
Why?
|
| Research Personnel | 1 | 2022 | 191 | 0.040 |
Why?
|
| Oxygen | 1 | 2002 | 217 | 0.040 |
Why?
|
| Plasmodium falciparum | 1 | 2002 | 146 | 0.040 |
Why?
|
| Uncertainty | 1 | 2021 | 32 | 0.040 |
Why?
|
| Young Adult | 3 | 2018 | 4936 | 0.040 |
Why?
|
| Professional Role | 1 | 2021 | 40 | 0.040 |
Why?
|
| Granzymes | 1 | 2020 | 19 | 0.040 |
Why?
|
| DNA Methylation | 2 | 2015 | 393 | 0.040 |
Why?
|
| Child | 3 | 2018 | 3381 | 0.040 |
Why?
|
| Electrophoresis, Capillary | 1 | 2020 | 20 | 0.040 |
Why?
|
| Protein Sorting Signals | 1 | 2000 | 26 | 0.040 |
Why?
|
| Alanine | 1 | 2000 | 33 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2009 | 1068 | 0.040 |
Why?
|
| Patient Participation | 1 | 2021 | 87 | 0.040 |
Why?
|
| Reference Standards | 1 | 2019 | 55 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2020 | 90 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 244 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2010 | 97 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 50 | 0.040 |
Why?
|
| Biological Transport | 1 | 2000 | 201 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 366 | 0.040 |
Why?
|
| Motivation | 1 | 2023 | 492 | 0.040 |
Why?
|
| United States | 3 | 2022 | 5072 | 0.040 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2019 | 12 | 0.040 |
Why?
|
| Founder Effect | 1 | 2019 | 9 | 0.040 |
Why?
|
| Public Opinion | 1 | 2019 | 20 | 0.040 |
Why?
|
| Models, Molecular | 3 | 2011 | 875 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2019 | 146 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 173 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2010 | 96 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 115 | 0.040 |
Why?
|
| Patient Selection | 1 | 2020 | 192 | 0.040 |
Why?
|
| Rhodobacter capsulatus | 1 | 1998 | 1 | 0.040 |
Why?
|
| Proteus | 1 | 1998 | 2 | 0.040 |
Why?
|
| British Columbia | 2 | 2011 | 19 | 0.040 |
Why?
|
| Neurons | 3 | 2011 | 1246 | 0.040 |
Why?
|
| Pregnancy | 2 | 2014 | 1737 | 0.040 |
Why?
|
| Plant Diseases | 2 | 2011 | 61 | 0.040 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 3 | 0.040 |
Why?
|
| Selection, Genetic | 2 | 2010 | 75 | 0.040 |
Why?
|
| Automation | 1 | 1998 | 23 | 0.040 |
Why?
|
| BRCA2 Protein | 1 | 2018 | 50 | 0.040 |
Why?
|
| BRCA1 Protein | 1 | 2018 | 58 | 0.030 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 16 | 0.030 |
Why?
|
| Lymphoma, B-Cell | 1 | 2017 | 28 | 0.030 |
Why?
|
| Transfection | 2 | 2010 | 526 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 1051 | 0.030 |
Why?
|
| North America | 1 | 2017 | 85 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 2017 | 35 | 0.030 |
Why?
|
| Minority Groups | 1 | 2022 | 663 | 0.030 |
Why?
|
| Wound Healing | 1 | 2018 | 82 | 0.030 |
Why?
|
| Alternative Splicing | 2 | 2009 | 92 | 0.030 |
Why?
|
| Sequence Deletion | 2 | 2008 | 92 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2018 | 268 | 0.030 |
Why?
|
| Agglutinins | 1 | 1996 | 2 | 0.030 |
Why?
|
| Trypanosoma brucei brucei | 1 | 1998 | 82 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1996 | 57 | 0.030 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2016 | 6 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 274 | 0.030 |
Why?
|
| Complementarity Determining Regions | 1 | 2016 | 8 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cattle | 2 | 2009 | 505 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2009 | 158 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2016 | 13 | 0.030 |
Why?
|
| Retinal Bipolar Cells | 1 | 2016 | 3 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 1516 | 0.030 |
Why?
|
| Exons | 2 | 2010 | 91 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 21 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 2008 | 134 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 75 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2016 | 39 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 708 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 1996 | 117 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2019 | 526 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2018 | 247 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 845 | 0.030 |
Why?
|
| Arabidopsis | 2 | 2008 | 102 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2015 | 10 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 12 | 0.030 |
Why?
|
| Plant Extracts | 2 | 2010 | 303 | 0.030 |
Why?
|
| Saliva | 1 | 1996 | 115 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 850 | 0.030 |
Why?
|
| Age Factors | 2 | 2011 | 1139 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 522 | 0.030 |
Why?
|
| RNA, Untranslated | 2 | 2005 | 46 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 167 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1994 | 35 | 0.030 |
Why?
|
| Vaccination | 1 | 2016 | 332 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2015 | 69 | 0.030 |
Why?
|
| Rats | 3 | 2009 | 3701 | 0.030 |
Why?
|
| Genetic Markers | 2 | 2007 | 146 | 0.030 |
Why?
|
| Zebrafish | 2 | 2006 | 146 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 276 | 0.030 |
Why?
|
| COUP Transcription Factor II | 1 | 2013 | 1 | 0.030 |
Why?
|
| Telomere | 2 | 2004 | 59 | 0.030 |
Why?
|
| Nephroblastoma Overexpressed Protein | 1 | 2013 | 3 | 0.030 |
Why?
|
| Amacrine Cells | 1 | 2013 | 3 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 515 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 512 | 0.030 |
Why?
|
| Monoamine Oxidase | 1 | 2013 | 36 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2013 | 2 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 2485 | 0.030 |
Why?
|
| Base Composition | 2 | 2004 | 25 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2013 | 49 | 0.030 |
Why?
|
| Introns | 2 | 2004 | 80 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2013 | 102 | 0.030 |
Why?
|
| Feline Acquired Immunodeficiency Syndrome | 1 | 2013 | 2 | 0.030 |
Why?
|
| Autopsy | 1 | 2013 | 46 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2013 | 168 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1420 | 0.020 |
Why?
|
| Cats | 1 | 2013 | 80 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 774 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2012 | 15 | 0.020 |
Why?
|
| Genes, myc | 1 | 2012 | 30 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2013 | 118 | 0.020 |
Why?
|
| Conserved Sequence | 2 | 2003 | 121 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2013 | 150 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 40 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2012 | 140 | 0.020 |
Why?
|
| Neuroglia | 1 | 2013 | 131 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 51 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 1994 | 928 | 0.020 |
Why?
|
| Anaerobiosis | 2 | 2004 | 17 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1554 | 0.020 |
Why?
|
| Pregnancy Proteins | 1 | 2011 | 5 | 0.020 |
Why?
|
| Gene Products, env | 1 | 2011 | 23 | 0.020 |
Why?
|
| NADP | 1 | 2011 | 37 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 300 | 0.020 |
Why?
|
| Contact Tracing | 1 | 2011 | 22 | 0.020 |
Why?
|
| Phloem | 1 | 2010 | 2 | 0.020 |
Why?
|
| Mycelium | 1 | 2010 | 5 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2010 | 9 | 0.020 |
Why?
|
| Spores, Fungal | 1 | 2010 | 21 | 0.020 |
Why?
|
| Symbiosis | 1 | 2011 | 46 | 0.020 |
Why?
|
| Tongue Neoplasms | 1 | 2010 | 9 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2010 | 18 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 16 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1990 | 45 | 0.020 |
Why?
|
| Serotyping | 1 | 1990 | 37 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1990 | 68 | 0.020 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2010 | 5 | 0.020 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2010 | 71 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 71 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 148 | 0.020 |
Why?
|
| Cocaine-Related Disorders | 1 | 2011 | 99 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1990 | 86 | 0.020 |
Why?
|
| Pyrroles | 1 | 2010 | 68 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1990 | 196 | 0.020 |
Why?
|
| Exocytosis | 1 | 2010 | 49 | 0.020 |
Why?
|
| Signal Recognition Particle | 1 | 2009 | 6 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2010 | 52 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 548 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 128 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2010 | 136 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2009 | 14 | 0.020 |
Why?
|
| Oils | 1 | 2009 | 6 | 0.020 |
Why?
|
| Immunodiffusion | 1 | 1989 | 4 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2009 | 8 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 1010 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1989 | 17 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 236 | 0.020 |
Why?
|
| Tyrosine | 1 | 2010 | 119 | 0.020 |
Why?
|
| Pyridines | 1 | 2010 | 134 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2009 | 35 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2009 | 4 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2012 | 355 | 0.020 |
Why?
|
| Silicon Dioxide | 1 | 2009 | 38 | 0.020 |
Why?
|
| Animals, Domestic | 1 | 2009 | 11 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 207 | 0.020 |
Why?
|
| Muscles | 1 | 2009 | 84 | 0.020 |
Why?
|
| RNA Editing | 1 | 2009 | 37 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 295 | 0.020 |
Why?
|
| Indoles | 1 | 2010 | 178 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2009 | 120 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 279 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 421 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2009 | 233 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2009 | 403 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 297 | 0.020 |
Why?
|
| Plicamycin | 1 | 2008 | 9 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 14 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 41 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 54 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 1054 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2007 | 20 | 0.020 |
Why?
|
| Statistical Distributions | 1 | 2007 | 3 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2007 | 26 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2007 | 18 | 0.020 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 2007 | 1 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2007 | 59 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 100 | 0.020 |
Why?
|
| Plant Proteins | 1 | 2008 | 100 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2010 | 633 | 0.020 |
Why?
|
| Microdissection | 1 | 2006 | 13 | 0.020 |
Why?
|
| Culture Media | 1 | 2007 | 96 | 0.020 |
Why?
|
| Pedigree | 1 | 2007 | 94 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 661 | 0.020 |
Why?
|
| Cell Separation | 1 | 2006 | 94 | 0.020 |
Why?
|
| Africa | 1 | 2006 | 81 | 0.020 |
Why?
|
| Asia | 1 | 2006 | 99 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 135 | 0.020 |
Why?
|
| Fruit | 1 | 2007 | 178 | 0.020 |
Why?
|
| Inflammation | 1 | 2011 | 729 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2006 | 131 | 0.010 |
Why?
|
| Cell Wall | 1 | 2005 | 55 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2005 | 111 | 0.010 |
Why?
|
| Replication Origin | 1 | 2004 | 15 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 2004 | 35 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2004 | 24 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 1848 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 2004 | 82 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2004 | 10 | 0.010 |
Why?
|
| Retroelements | 1 | 2004 | 14 | 0.010 |
Why?
|
| Centromere | 1 | 2004 | 21 | 0.010 |
Why?
|
| Aerobiosis | 1 | 2004 | 15 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2005 | 181 | 0.010 |
Why?
|
| Chickens | 1 | 2004 | 148 | 0.010 |
Why?
|
| Frameshifting, Ribosomal | 1 | 2003 | 1 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2004 | 420 | 0.010 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2003 | 7 | 0.010 |
Why?
|
| Nucleocapsid Proteins | 1 | 2003 | 12 | 0.010 |
Why?
|
| Coronavirus | 1 | 2003 | 9 | 0.010 |
Why?
|
| Viral Matrix Proteins | 1 | 2003 | 18 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 454 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2003 | 20 | 0.010 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2002 | 8 | 0.010 |
Why?
|
| Pseudogenes | 1 | 2002 | 12 | 0.010 |
Why?
|
| Chloride Peroxidase | 1 | 2002 | 1 | 0.010 |
Why?
|
| Acinetobacter | 1 | 2002 | 9 | 0.010 |
Why?
|
| Oxygenases | 1 | 2002 | 6 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2004 | 185 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 2002 | 7 | 0.010 |
Why?
|
| Dioxygenases | 1 | 2002 | 12 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 59 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 3942 | 0.010 |
Why?
|
| Viral Envelope Proteins | 1 | 2003 | 90 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2002 | 72 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 69 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2002 | 37 | 0.010 |
Why?
|
| Catalysis | 1 | 2002 | 191 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2004 | 560 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 427 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 183 | 0.010 |
Why?
|
| Dimethyl Sulfoxide | 1 | 1998 | 15 | 0.010 |
Why?
|
| Oxidants | 1 | 1998 | 43 | 0.010 |
Why?
|